ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 85 filers reported holding ACCELERON PHARMA INC in Q3 2014. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $882,000 | +7.4% | 7,033 | +16.1% | 0.00% | 0.0% |
Q1 2021 | $821,000 | +0.7% | 6,058 | -5.0% | 0.00% | 0.0% |
Q4 2020 | $815,000 | -13.6% | 6,375 | -24.0% | 0.00% | -25.0% |
Q3 2020 | $943,000 | +28.1% | 8,386 | +8.5% | 0.00% | +33.3% |
Q2 2020 | $736,000 | +15.4% | 7,727 | +8.8% | 0.00% | 0.0% |
Q1 2020 | $638,000 | +762.2% | 7,100 | +407.1% | 0.00% | – |
Q4 2019 | $74,000 | -76.4% | 1,400 | -83.9% | 0.00% | -100.0% |
Q3 2016 | $314,000 | -44.9% | 8,700 | -48.2% | 0.00% | -66.7% |
Q2 2016 | $570,000 | +83.3% | 16,800 | +34.4% | 0.00% | +200.0% |
Q3 2015 | $311,000 | -21.3% | 12,500 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $395,000 | -16.8% | 12,500 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $475,000 | -2.5% | 12,500 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $487,000 | +5.9% | 12,500 | -17.8% | 0.00% | +100.0% |
Q3 2014 | $460,000 | +736.4% | 15,200 | +850.0% | 0.00% | – |
Q1 2014 | $55,000 | -46.6% | 1,600 | -38.5% | 0.00% | – |
Q4 2013 | $103,000 | – | 2,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |